On November 14th, 2018, The Ministry of Health (MOH) informed all stakeholders that all regulatory functions will be transferred from the Drugs Regulatory Unit (a MOH Unit) to the newly formed Botswana Medicines Regulatory Authority (BoMRA). This will effect on December 1st, 2018. The regulatory scope of BoMRA is wider than the 6 DRU functions listed on the document below. As stated, it includes medical devices, cosmetics, and veterinary products. At SRC, we believe that BoMRA will bring better, faster and more effective regulatory systems. We expect a lot to change in the next few months and years. Our aim is to ensure that our clients are up to date with all changes, not only for compliance purposes but in a way that will enable them to make sound strategic decisions based on quality regulation intelligence. Schedule a call with us.
READ THE FULL DOCUMENT HERE